Jun 18, 2020 / 05:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the NATCO Pharma Limited Q4 FY '20 Results Conference Call, hosted by Axis Capital Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Prakash Agarwal of Axis Capital Limited. Thank you, and over to you, sir.
Prakash Agarwal - Axis Capital Limited, Research Division - Executive Director of Pharmaceuticals
Yes. Thanks, and good morning, everyone. On behalf of Axis Capital, I welcome you all for the NATCO Pharma Fourth Quarter Fiscal 2020 Earnings Call. Today, we have the senior management represented by Mr. Rajeev Nannapaneni, Vice Chairman and CEO; and Mr. Rajesh Chebiyam, Vice President, Acquisitions, Investor Relations and Corporate Communications.
I'd like to hand over the call to Mr. Rajesh. Thank you.
Rajesh Chebiyam - NATCO Pharma Limited - VP of Acquisitions, Institutional Investor Management & Corporate Communications
Thank you, Prakash. Good morning, and welcome,
Q4 2020 Natco Pharma Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot